Magdalena Cerda
Magdalena Cerdá, DrPH
NYU Langone Health - Associate Professor, Department of Population Health and Department of Emergency Medicine
NYU Langone Health - Director, Center on Opioid Epidemiology and Policy
DrPH, Public Health, Harvard University, School of Public Health
MPH, Public Health, Yale University
BS, Communication, Cornell University, Agriculture and Life Sciences
Research Interests
Opioid use disorder, Violence prevention, Firearms, Prescription drugs, Heroin, Drug overdose, Social determinants of injury, Marijuana, Homicide, Suicide
Magdalena Cerdá is Associate Professor of Population Health at New York University Langone Health and Director of the NYU Center on Opioid Epidemiology and Policy. Her work integrates approaches from social and psychiatric epidemiology to examine how social contexts shape violent behavior, substance use and common forms of mental illness. Her expertise extends to the epidemiology and policy determinants of substance use with a particular focus on opioid and marijuana use, including two NIDA-funded studies to examine the impact that prescription opioid policies and marijuana legalization have on opioid prescribing, chronic pain, and opioid overdoses, and a NIDA-funded study to examine the impact that national marijuana legalization in Uruguay has on substance use.  Dr. Cerdá also uses agent-based models to simulate the potential impact of city- and neighborhood-level prevention programs and policies on violence. Prior to joining NYU, Dr. Cerdá served as the Vice-Chancellor’s Endowed Chair on Violence Prevention at UC-Davis and on the faculty at the Columbia Mailman School of Public Health. Dr. Cerdá received her DrPH from Harvard University and was a Robert Wood Johnson Health and Society Scholar at the University of Michigan.
Principal Investigator, Examining the Synergistic Effects of Cannabis and Prescription Opioid Policies on Chronic Pain, Opioid Prescribing, and Opioid Overdose. Active
Principal Investigator, Reducing Drug-Related Mortality Using Predictive Analytics: A Randomized, Statewide, Community Intervention Trial. Active
Principal Investigator, Health and Social Consequences of Marijuana Legalization. Completed
Principal Investigator, Prescription Drug Monitoring Programs and Opioid-Related Harm. Completed
Principal Investigator, Substance Abuse History, Mental Health and Firearm Violence: From Evidence To Action. Completed


Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerda M (2022).
What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
Drug and Alcohol Dependence Reports, 3, 100052. doi: 10.1016/j.dadr.2022.100052.

Hasin DS, Fink DS, Olfson M, Saxon AJ, Malte C, Keyes KM, Gradus JL, Cerda M, Maynard CC, Keyhani S, Martins SS, Livne O, Mannes ZL, Sherman SE, Wall MM (2022).
Substance use disorders and COVID-19: An analysis of nation-wide Veterans Health Administration electronic health records
Drug and Alcohol Dependence, 234, 109383. doi: 10.1016/j.drugalcdep.2022.109383. PMCID: PMC8891118.

Kreski NT, Chen Q, Olfson M, Cerda M, Martins SS, Mauro PM, Hasin DS, Keyes KM (2022).
National trends and disparities in bullying and suicidal behavior across demographic subgroups of US adolescents
Journal of the American Academy of Child and Adolescent Psychiatry [Epub 2022 Apr 26]. doi: 10.1016/j.jaac.2022.04.011.

Allen B, Jent VA, Cerda M (2022).
Cycles of chronic opioid therapy following mandatory prescription drug monitoring program legislation: A retrospective cohort study
Journal of General Internal Medicine [Epub 2022 Apr 11]. doi: 10.1007/s11606-022-07551-z.

Keyes KM, Cerda M (2022).
Dynamics of drug overdose in the 20th and 21st centuries: The exponential curve was not inevitable, and continued increases are preventable
International Journal of Drug Policy [Epub 2022 Apr 8]. doi: 10.1016/j.drugpo.2022.103675.


Castillo-Carniglia A, Ponicki W, Gaidus A, Gruenewald P, Marshall BDL, Fink DS, Martins SS, Rivera-Aguirre A, Wintemute G, Cerda M (2019).
Prescription drug monitoring programs and opioid overdoses: Exploring sources of heterogeneity
Epidemiology, 30 (2), 212-220. doi: 10.1097/EDE.0000000000000950. PMCID: PMC6437666.

Cerda M, Wall M, Feng T, Keyes KM, Sarvet A, Schulenberg J, O'Malley PM, Pacula RL, Galea S, Hasin DS (2017).
Association of state recreational marijuana laws with adolescent marijuana use
JAMA Pediatrics, 171 (2), 142-149. doi: 10.1001/jamapediatrics.2016.3624. PMCID: PMC5365078.

Dr. Cerdá's Google Scholar Profile
Selected Press